PCM
OGN icon

Peregrine Capital Management’s Organon & Co OGN Stock Holding History

Peregrine Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-535,830
Closed -$5.72M – 336
2025
Q3 		$5.72M Sell
535,830
-898
-0.2% -$8.81K 0.17% 176
2025
Q2 		$5.2M Buy
536,728
+267,016
+99% +$2.75M 0.16% 195
2025
Q1 		$4.02M Sell
269,712
-14,649
-5% -$225K 0.13% 227
2024
Q4 		$4.24M Sell
284,361
-9,897
-3% -$161K 0.13% 238
2024
Q3 		$5.63M Sell
294,258
-95,392
-24% -$1.98M 0.17% 196
2024
Q2 		$8.07M Sell
389,650
-1,341
-0.3% -$26.6K 0.24% 120
2024
Q1 		$7.35M Buy
+390,991
New +$6.71M 0.21% 159

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Peregrine Capital Management's OGN Position: Q4 2025 in Review

Peregrine Capital Management sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 535,830 shares — an estimated $5.72M sold.

Peregrine Capital Management first reported a position in OGN in Q1 2024 and held it in 7 quarters. The position peaked at $8.07M in Q2 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Peregrine Capital Management reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Peregrine Capital Management sold 535,830 Organon & Co shares in Q4 2025, an estimated $5.72M.
  • Peregrine Capital Management first reported a position in Organon & Co in Q1 2024 and held it in 7 quarters.
  • Peregrine Capital Management's Organon & Co position peaked at $8.07M in Q2 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Peregrine Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.